Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:49:46 EDT Sat 15 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Z:QGEN - QIAGEN NV - https://www.qiagen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
QGEN - Z0.135.32·43.400.139.48+0.591.5858.432,8108,76139.21  39.51  38.9249.2891  37.6316:33:44Mar 0615 min RT 2¢

Recent Trades - Last 10 of 8761
Time ETExPriceChangeVolume
16:33:44Z39.480.5818,994
16:05:11Z39.480.581
16:01:19Z39.480.58759
16:01:19Z39.480.58106
16:01:04Z39.480.5865
16:00:46Z39.480.58167
16:00:32Z39.480.5844
16:00:28Z39.480.58501
16:00:28Z39.480.58286
16:00:28Z39.480.588,927

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-03-06 01:00U:QGENNews ReleaseQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
2025-03-03 01:00U:QGENNews ReleaseQIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
2025-02-13 16:05U:QGENNews ReleaseQIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
2025-02-05 16:05U:QGENNews ReleaseQIAGEN delivers solid Q4 2024 growth ahead of outlook
2025-02-04 16:05U:QGENNews ReleaseQIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
2025-01-16 16:05U:QGENNews ReleaseQIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million
2025-01-15 08:13U:QGENNews ReleaseQIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
2025-01-12 13:05U:QGENNews ReleaseQIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase
2025-01-10 01:30U:QGENNews ReleaseQIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
2025-01-09 16:05U:QGENNews ReleaseQIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care
2025-01-07 16:05U:QGENNews ReleaseQIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content
2024-12-12 16:05U:QGENNews ReleaseQIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
2024-12-05 16:05U:QGENNews ReleaseQIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
2024-11-28 06:00U:QGENNews ReleaseQIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
2024-11-27 16:05U:QGENNews ReleaseQIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
2024-11-12 16:05U:QGENNews ReleaseQIAGEN collaborates with McGill University to advance microbiome research
2024-11-06 16:05U:QGENNews ReleaseQIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
2024-11-04 01:30U:QGENNews ReleaseQIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
2024-10-29 02:30U:QGENNews ReleaseQIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
2024-10-10 16:05U:QGENNews ReleaseQIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications